Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 1975 Records) |
Query Trace: CYP2C19[original query] |
---|
PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes. Archives of pharmacal research 2023 12 . Chang-Keun Cho, Eunvin Ko, Ju Yeon Mo, Pureum Kang, Choon-Gon Jang, Seok-Yong Lee, Yun Jeong Lee, Jung-Woo Bae, Chang-Ik Ch |
A genome-wide association study of 24-hour urinary excretion of endocrine disrupting chemicals. Environment international 2023 12 183 108396. Xueling Lu, Thomas P van der Meer, Zoha Kamali, Martijn van Faassen, Ido P Kema, André P van Beek, Xijin Xu, Xia Huo, Alireza Ani, , Ilja M Nolte, Bruce H R Wolffenbuttel, Jana V van Vliet-Ostaptchouk, Harold Snied |
Effect of CYP2C19 Pharmacogenetic Testing on Predicting Citalopram and Escitalopram Tolerability and Efficacy: A Retrospective, Longitudinal Cohort Study. Biomedicines 2023 12 11 (12): . Mahmood Mahajna, Rami Abu Fanne, Matitiahu Berkovitch, Elias Tannous, Shlomo Vinker, Ilan Green, Ilan Mat |
Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in CYP2C19 loss-of -function carriers with minor stroke or transient ischaemic attack: a post-hoc analysis of the CHANCE-2 trial. EClinicalMedicine 2023 12 67 102357. Anxin Wang, Xue Tian, Xuewei Xie, Hao Li, Jing Jing, Jinxi Lin, Yilong Wang, Xingquan Zhao, Zixiao Li, Liping Liu, Yongjun Wang, Xia Me |
Investigation of genomic and transcriptomic risk factors in clopidogrel response in African Americans. medRxiv : the preprint server for health sciences 2023 12 . Guang Yang, Cristina Alarcon, Catherine Chanfreau, Norman H Lee, Paula Friedman, Edith Nutescu, Matthew Tuck, Travis O'Brien, Li Gong, Teri E Klein, Kyong-Mi Chang, Philip S Tsao, David O Meltzer, , Sony Tuteja, Minoli A Pere |
Utility of the ACD-GENE-CLI Score in Asian Patients with Critical Limb Ischemia Undergoing Endovascular Interventions. Journal of atherosclerosis and thrombosis 2023 12 . Wei-Ting Chang, Po-Sen Huang, Li-Wei Su, Chia-Te Liao, Han Siong Toh, Yi-Chen Chen, Chung-Han Ho, Zhih-Cherng Chen, Po-Chao Hsu, Chon-Seng Ho |
Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers. Xenobiotica; the fate of foreign compounds in biological systems 2023 12 1-28. Ying-Rong Chen, Xiang Yu, Li-Min Xu, Jue Mei, Meng-Li Tian, Min Xu, Qiu-Yue Jin, Li-Bing Ye, Shui-Xin Ya |
Cytochrome P-450 CYP2C19 genetic polymorphism and its relation with clopidogrel resistance. JPMA. The Journal of the Pakistan Medical Association 2023 12 73 (12): 2388-2392. Usman Nawaz, Mudassar Noor, Akbar Wahe |
Most patients with disorders of gut-brain interaction receive pharmacotherapy with major or moderate drug-gene interactions. Neurogastroenterology and motility 2023 12 e14722. Revati Varma, Jeffrey P Staab, Eric T Matey, Jessica A Wright, Brototo Deb, Konstantinos N Lazaridis, Lawrence A Szarka, Kent R Bailey, Adil E Bharuc |
Impact of CYP2C19 Genotype on Efficacy and Safety of Clopidogrel-based Antiplatelet Therapy in Stroke or Transient Ischemic Attack Patients: An Updated Systematic Review and Meta-analysis of Non-East Asian Studies. Cardiovascular drugs and therapy 2023 12 . Sarah Cargnin, Federica Ferrari, Salvatore Terrazzi |
Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing. The pharmacogenomics journal 2023 11 . Jai N Patel, Myra Robinson, Sarah A Morris, Elizabeth Jandrisevits, Karine Eboli Lopes, Alicia Hamilton, Nury Steuerwald, Lawrence J Druhan, Belinda Avalos, Edward Copelan, Nilanjan Ghosh, Michael R Grunwa |
Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone. Clinical pharmacology and therapeutics 2023 11 . Intishar Kazi, Meghan J Chenoweth, Didier Jutras-Aswad, Keith Ahamad, M Eugenia Socias, Bernard Le Foll, Rachel F Tynda |
Pharmacogenomic evaluation of CYP2C19 alleles linking low clopidogrel response and the risk of acute coronary syndrome in Indians. The journal of gene medicine 2023 11 e3634. Keshavamurthy Ganapathy Bhat, Ratheesh Kumar Janardhana Pillai, Heemanshu Lodhi, Vivek Singh Guleria, Anil Kumar Abbot, Love Gupta, Garima Rastogi, Anuka Sharma, Zafar Mohammed, Varun Shar |
CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention (PCI) in the Million Veterans Program. medRxiv : the preprint server for health sciences 2023 11 . Catherine Chanfreau-Coffinier, Kevin A Friede, Mary E Plomondon, Kyung Min Lee, Zhenyu Lu, Julie A Lynch, Scott L DuVall, Jason L Vassy, Stephen W Waldo, John H Cleator, Thomas M Maddox, Daniel J Rader, Themistocles L Assimes, Scott M Damrauer, Philip S Tsao, Kyong-Mi Chang, Deepak Voora, Jay Giri, Sony Tute |
Role of genetic polymorphisms in clopidogrel response variability: a systematic review. Open heart 2023 11 10 (2): . Jose Lopez, Justin Mark, Gustavo J Duarte, Mohammed Shaban, Franklin Sosa, Rishabh Mishra, Swati Jain, An Tran, Asma Khizar, Daniel Karpel, Giancarlo Acosta, Miguel Rodriguez-Guer |
Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington's disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogenetics. Therapeutic advances in rare disease 2023 11 4 26330040231204643. Stephanie Feleus, Maaike van der Lee, Jesse J Swen, Raymund A C Roos, Susanne T de B |
CYP2C19 *2/*2 Genotype is a Risk Factor for Multi-Site Arteriosclerosis: A Hospital-Based Cohort Study. International journal of general medicine 2023 11 16 5139-5146. Jieyao Xie, Tingjun Pan, Weiwen Luo, Songsheng Zhang, Yuquan Fang, Zhou |
Genetic polymorphisms of CYP2C19 in ecuadorian population: An interethnic approach. Heliyon 2024 4 10 (7): e28566. Alba Alonso Llorente, Josefa Salgado Garrido, Óscar Teijido Hermida, Fabricio González Andrade, Alberto Valiente Martín, Ana Julia Fanlo Villacampa, Jorge Vicente Rome |
The association of CYP2C19 LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta-analysis. Clinical and translational science 2024 4 17 (4): e13792. Mohitosh Biswas, Md Shahadat Hossain, Tahsin Ahmed Rupok, Md Sabbir Hossain, Chonlaphat Sukas |
Phenotype-Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism. Clinical pharmacology and therapeutics 2024 4 . Ruwen Böhm, Henrike Bruckmueller, Stefan Oswald, Matthias Hübenthal, Meike Kaehler, Lena Ehmke, Jan Höcker, Werner Siegmund, Andre Franke, Ingolf Cascor |
Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis. International journal of molecular sciences 2024 4 25 (7): . Paula Soria-Chacartegui, Marcos Navares-Gómez, Francisca Molina-Jiménez, Emilio J Laserna-Mendieta, Laura Arias-González, Pedro Majano, Sergio Casabona, Alfredo J Lucendo, Francisco Abad-Santos, Cecilio Santander, Pablo Zubia |
Effectiveness of Clopidogrel vs Alternative P2Y Inhibitors Based on the ABCD-GENE Score. Journal of the American College of Cardiology 2024 4 83 (15): 1370-1381. Cameron D Thomas, Francesco Franchi, Joseph S Rossi, Ellen C Keeley, R David Anderson, Amber L Beitelshees, Julio D Duarte, Luis Ortega-Paz, Yan Gong, Richard A Kerensky, Natasha Kulick, Caitrin W McDonough, Anh B Nguyen, Yehua Wang, Marshall Winget, William E Yang, Julie A Johnson, Almut G Winterstein, George A Stouffer, Dominick J Angiolillo, Craig R Lee, Larisa H Cavalla |
Exploring clozapine pharmacokinetics in Tunisian schizophrenic patients: A population-based modelling approach investigating the impact of genetic and non-genetic variables. Basic & clinical pharmacology & toxicology 2024 4 . Khadija Mansour, Nadia Ben Fredj, Helmi Ammar, Haifa Ben Romdhane, Ahmed Mhalla, Amel Chaabane, Zohra Chadli, Karim Aou |
Pharmacogenetics at scale in real-world bioresources: CYP2C19 and clopidogrel outcomes in UK Biobank. Pharmacogenetics and genomics 2024 1 . Khaled F Bedair, Blair Smith, Colin N A Palmer, Alex S F Doney, Ewan R Pears |
The diversity and clinical implications of genetic variants influencing clopidogrel bioactivation and response in the Emirati population. Human genomics 2024 1 18 (1): 2. Lubna Q Khasawneh, Habiba Alsafar, Hiba Alblooshi, Mushal Allam, George P Patrinos, Bassam R A |
Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago. Cardiology and therapy 2024 1 . Daniele Jones, Shana Persad-Ramdeensingh, Sheherazade Crystal Abrahim, Naveen Seecheran, Rajini Rani Haraksin |
A novel AllGlo probe-quantitative PCR method for detecting single nucleotide polymorphism in CYP2C19 to evaluate the antiplatelet activity of clopidogrel. Scientific reports 2024 1 14 (1): 2358. Hongwei Li, Yizhen Fang, Yongquan Chen, Yuning Lin, Zanxi Fang, Zhiyuan Lin, Huabin Xie, Zhongying Zha |
Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial. Stroke and vascular neurology 2024 1 . Xinmiao Zhang, Jing Jing, Anxin Wang, Xuewei Xie, S Claiborne Johnston, Hao Li, Philip M Bath, Qin Xu, Jinxi Lin, Yilong Wang, Xingquan Zhao, Zixiao Li, Yong Jiang, Liping Liu, Weifeng Chen, Xuhai Gong, Jianhua Li, Xinsheng Han, Xia Meng, Yongjun Wa |
Relationships of Proton Pump Inhibitor-Induced Renal Injury with CYP2C19 Polymorphism: A Retrospective Cohort Study. Clinical pharmacology and therapeutics 2024 1 . Rika Fukui, Satoshi Noda, Yoshito Ikeda, Yuichi Sawayama, Tomohiro Terada, Yoshihisa Nakagawa, Shin-Ya Mori |
The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI): Affectability of Rapid Genetic Testing. Cardiovascular drugs and therapy 2024 1 . Mohammed Ahmed Akkaif, Nur Aizati Athirah Daud, Dzul Azri Mohamed Noor, Abubakar Sha'aban, Muhamad Ali Sk Abdul Kader, Baharudin Ibrah |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: